Stay updated on Hyperthermia Immunotherapy in Abdominal-Pelvic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Hyperthermia Immunotherapy in Abdominal-Pelvic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Hyperthermia Immunotherapy in Abdominal-Pelvic Malignancies Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov record now displays details of the completed study, including its eligibility criteria, treatment groups, interventions, and outcome measures.
    Difference
    52%
    Check dated 2026-11-10T20:43:34.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T21:20:26.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    A general NIH notice about the terminology transition appears above the 403 error page, and the site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T21:50:48.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.0 to v3.7.1; the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T21:53:02.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, removing the detailed study information from view. The error page includes the site header and a restricted-access message.
    Difference
    19%
    Check dated 2026-09-22T23:20:35.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page shows revision v3.7.0, indicating a new release or update to the record. This update does not alter the study details or clinical information presented.
    Difference
    0.1%
    Check dated 2026-09-15T22:21:43.000Z thumbnail image

Stay in the know with updates to Hyperthermia Immunotherapy in Abdominal-Pelvic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Hyperthermia Immunotherapy in Abdominal-Pelvic Malignancies Clinical Trial page.